Caleres Inc (CAL)
Return on equity (ROE)
| Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Feb 3, 2024 | Jan 31, 2024 | Oct 31, 2023 | Oct 28, 2023 | Jul 31, 2023 | Jul 29, 2023 | Apr 30, 2023 | Apr 29, 2023 | Jan 31, 2023 | Jan 28, 2023 | Oct 31, 2022 | Oct 29, 2022 | Jul 31, 2022 | Jul 30, 2022 | Apr 30, 2022 | Jan 31, 2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 106,046 | 156,923 | 171,303 | 188,259 | 205,442 | 183,578 | 161,714 | 149,527 | 137,340 | 144,206 | 151,072 | 155,591 | 160,110 | 170,479 | 180,848 | 192,111 | 186,719 | 169,395 | 177,839 | 186,952 |
| Total stockholders’ equity | US$ in thousands | 599,024 | 598,284 | 606,062 | 570,304 | 560,631 | 560,631 | 513,382 | 513,382 | 464,992 | 464,992 | 446,317 | 446,317 | 420,683 | 420,683 | 398,444 | 398,444 | 379,133 | 379,133 | 352,236 | 318,570 |
| ROE | 17.70% | 26.23% | 28.26% | 33.01% | 36.64% | 32.74% | 31.50% | 29.13% | 29.54% | 31.01% | 33.85% | 34.86% | 38.06% | 40.52% | 45.39% | 48.22% | 49.25% | 44.68% | 50.49% | 58.68% |
January 31, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $106,046K ÷ $599,024K
= 17.70%
Caleres Inc's return on equity (ROE) has shown a general declining trend over the period from January 31, 2022, to January 31, 2025. Starting at a robust level of 58.68% in January 2022, the ROE gradually decreased to 17.70% by January 2025.
The decreasing trend in ROE indicates a declining profitability relative to shareholders' equity. This may be a cause for concern as it suggests that the company's ability to generate profits from its equity base has weakened over time.
It is essential for Caleres Inc to identify the factors contributing to this decline in ROE and take appropriate measures to improve profitability and efficiency. Analyzing key aspects like revenue growth, cost management, asset utilization, and debt levels can provide insights into enhancing the company's return on equity in the future.
Peer comparison
Jan 31, 2025